At BaseLaunch, we partner with scientists and entrepreneurs to help launch and grow exceptional biotech companies developing cutting-edge therapeutics. To achieve this, we collaborate closely with key players from the biotech sector, leading pharmaceutical companies and venture funds. Our world-class partners include Roche, BB Pureos Bioventures, Roivant Sciences, Bridge Bioventures, CSL Behring, Johnson & Johnson Innovation.
What does BaseLaunch look for in applications?
- We are looking for breakthrough innovations that can form the basis of new biopharma ventures, from all over the world
- We only accept applications for therapeutic products or platform projects (but within this we are interested in all modalities and disease areas)
- We are interested in projects at any stage, from pre-seed to seed, at the very beginning, or even before. Additionally, projects where the only person involved is the Post Doc or Professor – with a promising discovery but no one else to develop it – are perfectly acceptable for us
- Even if you believe your project is not yet mature enough to apply, we recommend that you get in touch with us
- Already received seed funding or a small Series A? No worries, we may still be able to help you further your reach
What support does BaseLaunch provide to selected ventures?
- Apart from the direct funding of up to $500,000, we provide access to our partners, global biopharma & investors, and our network
- We help launch and build ventures to the point where they can complete a Series A financing or similar, doing whatever it takes
- We can provide access to best-in-class scientific avenues– discussing topics as detailed as assay levels, animal models etc. – with strategic breadth – defining key milestones to de-risk the science or sharpening overall positioning
- We can help build out the team, provide support with IP licencing, and can provide infrastructure, among other support
- We know every project is different, so we work with that in mind to provide tailored support for each venture in our portfolio
What is the track record of BaseLaunch supported companies?
Our portfolio of companies that we have supported includes Alentis Therapeutics, Anaveon, T3 Pharma, and Polyneuron among others. So far our portfolio has raised over $270M in venture financing with an average raise of $34M per company.
“There is no other incubator like BaseLaunch and Alentis would not exist without it. BaseLaunch has backed us in critical times and was invaluable on all aspects of getting the company launched, being it on licensing our IP, helping assemble the initial team or supporting our series A financing. To this day, from time to time we still make use of their support and incredible network.”
Thomas Baumert Founder and Executive BoD, Alentis Therapeutics
How do I apply?
It is very easy, simply visit baselaunch.ch/apply, and fill out the form which helps us understand what your projects is about. We will review and get back quickly.
Learn more, see list of all our portfolio companies, and apply now before the next deadline!
Please login or sign up to comment.
Commenting guidelines